Treatment and Dosimetric Advantages Between VMAT, IMRT, and Helical TomoTherapy in Prostate Cancer

Medical Dosimetry

Volumn 36, Issue 3, 2011, Pages 264-271

  Tsai, Chiao Ling ^a   Wu, Jian Kuen ^a   Chao, Hsiao Ling ^a   Tsai, Yi Chun ^a   Cheng, Jason Chia Hsien ^a,b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Helical tomotherapy; Intensity modulated radiation therapy; Prostate cancer; Volumetric modulated arc therapy

Indexed keywords

AGED; ARTICLE; BLADDER; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DOSIMETRY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; MALE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RECTUM; STEP AND SHOOT INTENSITY MODULATED RADIATION THERAPY; TOMOTHERAPY; TREATMENT DURATION; TREATMENT PLANNING; VOLUMETRIC MODULATED ARC THERAPY;

AGED; HUMANS; MALE; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, IMAGE-GUIDED; RADIOTHERAPY, INTENSITY-MODULATED; TOMOGRAPHY, SPIRAL COMPUTED;

EID: 79960923672     PISSN: 09583947     EISSN: 18734022     Source Type: Journal    
DOI: 10.1016/j.meddos.2010.05.001     Document Type: Article

References (29)

1. Dearnaley D.P., Sydes M.R., Graham J.D., et al. Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial. Lancet. Oncol. 2007, 8:475-487.
2. Peeters S.T., Heemsbergen W.D., Koper P.C., et al. Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. J. Clin. Oncol. 2006, 24:1990-1996.
3. Zietman A.L., DeSilvio M.L., Slater J.D., et al. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. JAMA 2005, 294:1233-1239.
4. Pollack A., Zagars G.K., Starkschall G., et al. Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial. Int. J. Radiat. Oncol. Biol. Phys. 2002, 53:1097-1105.
5. Zelefsky M.J., Fuks Z., Happersett L., et al. Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer. Radiother. Oncol. 2000, 55:241-249.
6. Zelefsky M.J., Fuks Z., Hunt M., et al. High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. Int. J. Radiat. Oncol. Biol. Phys. 2002, 53:1111-1116.
7. Cahlon O., Hunt M., Zelefsky M.J. Intensity-modulated radiation therapy: supportive data for prostate cancer. Semin. Radiat. Oncol. 2008, 18:48-57.
8. Otto K. Volumetric modulated arc therapy: IMRT in a single gantry arc. Med. Phys. 2008, 35:310-317.
9. Pardo-Montero J., Fenwick J.D. An approach to multiobjective optimization of rotational therapy. Med. Phys. 2009, 36:3292-3303.
10. Kjaer-Kristoffersen F., Ohlhues L., Medin J., et al. RapidArc volumetric modulated therapy planning for prostate cancer patients. Acta. Oncol. 2009, 48:227-232.
11. Zhang P., Happersett L., Hunt M., et al. Volumetric modulated arc therapy: planning and evaluation for prostate cancer cases. IntJ. Radiat. Oncol. Biol. Phys. 2010, 76:1456-1462.
12. Tsai C.L., Wu J.K., Wang C.W., et al. Using cone-beam computed tomography to evaluate the impact of bladder filling status on target position in prostate radiotherapy. Strahlenther. Onkol. 2009, 185:588-595.
13. Holmes T.W., Mackie T.R., Reckwerdt P. An iterative filtered backprojection inverse treatment planning algorithm for tomotherapy. Int. J. Radiat. Oncol. Biol. Phys. 1995, 32:1215-1225.
14. Wilcox E.E., Daskalov G.M. Evaluation of GAFCHROMIC EBT film for Cyberknife dosimetry. Med. Phys. 2007, 34:1967-1974.
15. Low D.A., Gerber R.L., Mutic S., et al. Phantoms for IMRT dose distribution measurement and treatment verification. Int. J. Radiat. Oncol. Biol. Phys. 1998, 40:1231-1235.
16. Schreibmann E., Dhabaan A., Elder E., et al. Patient-specific quality assurance method for VMAT treatment delivery. Med. Phys. 2009, 36:4530-4535.
17. IMRT C.W.G. Intensity-modulated radiotherapy: current status and issues of interest. Int. J. Radiat. Oncol. Biol. Phys. 2001, 51:880-914.
18. Han C., Liu A., Schultheiss T.E., et al. Dosimetric comparisons of helical tomotherapy treatment plans and step-and-shoot intensity-modulated radiosurgery treatment plans in intracranial stereotactic radiosurgery. Int. J. Radiat. Oncol. Biol. Phys. 2006, 65:608-616.
19. Khan H.A. CalcNTCP: a simple tool for computation of normal tissue complication probability (NTCP) associated with cancer radiotherapy. Int. J. Radiat. Biol. 2007, 83:717-720.
20. Lyman J.T. Complication probability as assessed from dose-volume histograms. Radiat. Res. Suppl. 1985, 8:S13-S19.
21. Burman C., Kutcher G.J., Emami B., et al. Fitting of normal tissue tolerance data to an analytic function. Int. J. Radiat. Oncol. Biol. Phys. 1991, 21:123-135.
22. Wu Q., Mohan R., Niemierko A., et al. Optimization of intensity-modulated radiotherapy plans based on the equivalent uniform dose. Int. J. Radiat. Oncol. Biol. Phys. 2002, 52:224-235.
23. Palma D., Vollans E., James K., et al. Volumetric modulated arc therapy for delivery of prostate radiotherapy: comparison with intensity-modulated radiotherapy and three-dimensional conformal radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 2008, 72:996-1001.
24. Ulrich S., Sterzing F., Nill S., et al. Comparison of arc-modulated cone beam therapy and helical tomotherapy for three different types of cancer. Med. Phys. 2009, 36:4702-4710.
25. Enmark M., Korreman S., Nystrom H. IGRT of prostate cancer; is the margin reduction gained from daily IG time-dependent?. Acta. Oncol. 2006, 45:907-914.
26. Followill D., Geis P., Boyer A. Estimates of whole-body dose equivalent produced by beam intensity modulated conformal therapy. Int. J. Radiat. Oncol. Biol. Phys. 1997, 38:667-672.
27. Sterzing F., Schubert K., Sroka-Perez G., et al. Helical tomotherapy. Experiences of the first 150 patients in Heidelberg. Strahlenther. Onkol. 2008, 184:8-14.
28. Pollack A., Price R.A., Dong L., et al. Intact prostate cancer: overview. Intensity Modulated Radiation Therapy: A Clinical Perspective 2005, 459-463. BC Decker, Hamilton, ON, Canada. A.J. Mundt, J.C. Roeske (Eds.).
29. Teh B.S., Dong L., McGary J.E., et al. Rectal wall sparing by dosimetric effect of rectal balloon used during intensity-modulated radiation therapy (IMRT) for prostate cancer. Med. Dosim. 2005, 30:25-30.